A Study of Ianalumab in Addition to Eltrombopag in Pediatric Patients With Primary ITP Who Failed Corticosteroids.
Clinical trial NCT07660172 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07660172
- Sponsor
- Novartis Pharmaceuticals
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2027-02-08
- Primary completion
- 2033-04-22
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.